key: cord-1011438-9yg6gq6y
authors: Duan, Ya-ni; Qin, Jie
title: Pre- and Posttreatment Chest CT Findings: 2019 Novel Coronavirus (2019-nCoV) Pneumonia
date: 2020-02-12
journal: Radiology
DOI: 10.1148/radiol.2020200323
sha: 663e9987515c8a44b524102ec6ca2665156765cf
doc_id: 1011438
cord_uid: 9yg6gq6y

nan

pharyngeal swab was positive for 2019-nCoV nucleic acid 2 days after hospitalization.

After the patient received 7 days of treatment, combined with interferon inhalation, real-time fluorescence polymerase chain reaction of the patient's pharyngeal swab became negative for 2019-nCoV nucleic acid. At 7 days, chest CT showed decreasing ground-glass opacities (Figure b) . At day 13 after admission, the ground-glass opacities in the right lung had resolved; the left ground-glass opacities showed partial resolution (Figure c) . 

CT Imaging of the 2019 Novel Coronavirus (2019-nCoV) Pneumonia. Radiology 2020

Chest CT findings in 2019-nCoV infections from Wuhan

Transverse thin-section CT scan obtained at first day after admission shows multiple ground-glass opacities in both lungs. Ground-glass opacities are seen in the superior segment of both lower lobes. (b) Follow-up CT scan obtained on day 7 after admission shows ground-glass opacities are completely resolved in the superior segment of right lower lobe and partly resolved in the superior segment of left lower lobe. (c) Follow-up CT scan obtained at day 13 after admission shows ground-glass opacities are completely resolved in the superior segment of right lower lobe and partly resolved in the superior segment of left lower lobe. A 46-year-old woman presented to the hospital with a 7-day history of fever without chills and rigor, nasal discharge, cough, and myalgia. She had stayed with a friend who had been diagnosed with 2019 novel coronavirus (2019-nCoV) pneumonia in Wuhan

There were elevated blood levels for C-reactive protein (6.4 mg/L; normal range, 0-6 mg/L), erythrocyte sedimentation rate (27 mm/h; normal range, 0-20 mm/h), and D-dimer (566 ng/mL; normal range, 500 ng/mL)

Real-time fluorescence polymerase chain reaction of the patient's